Chromatin immunoprecipitation (ChIP) Sequencing Market Report Examines Industry Trends, Growth Drivers And Future Outlook

The chromatin immunoprecipitation (ChIP) sequencing market is poised for substantial expansion over the coming years, driven by technological advancements and growing research investments. This evolving field is set to transform genomic studies and precision medicine, offering promising opportunities for researchers and industry players alike. Let's delve into the market size projections, key drivers, major participants, ongoing innovations, and segmentation details shaping this dynamic sector.

Forecasted Market Growth and Size of the Chromatin Immunoprecipitation (ChIP) Sequencing Market
The market for chromatin immunoprecipitation sequencing is projected to reach $29.02 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 13.6%. This rapid increase is fueled by several factors including heightened funding for epigenomics research, widespread adoption of artificial intelligence in genomic analysis, the growing scope of precision medicine programs, escalating demand for multi-omics data integration, and the expanded use of cloud-based bioinformatics platforms. Key trends anticipated throughout the forecast period involve a surge in genome-wide protein-DNA interaction mapping, greater utilization of high-throughput sequencing technologies, rising need for epigenetics research tools, growth of integrated bioinformatics pipelines, and intensified focus on regulatory genomics studies.

The chromatin immunoprecipitation (chip) sequencing market size has grown rapidly in recent years. It will grow from $15.48 billion in 2025 to $17.42 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to expansion of basic genomics research, increasing academic research funding, availability of next-generation sequencing platforms, rising interest in chromatin biology, growth of molecular biology laboratories.

Download a free sample of the chromatin immunoprecipitation (chip) sequencing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Primary Players Leading the Chromatin Immunoprecipitation (ChIP) Sequencing Market
The market is dominated by several influential companies, including F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Becton dic*kinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd., Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., and EpiCypher Inc.

Significant Acquisition Enhancing Market Position
In December 2023, Danaher Corporation, a US-based science and technology conglomerate, acquired Abcam plc for an undisclosed sum. This acquisition represents Danaher's strategic move to bolster its portfolio within the life sciences sector, enhance its footprint in the global research tools market, accelerate innovation in antibody and protein research solutions, and broaden its capabilities supporting scientific discovery. Abcam plc, headquartered in the UK, is a notable provider of chromatin immunoprecipitation sequencing products.

View the full chromatin immunoprecipitation (chip) sequencing market report:
https://www.thebusinessresearchcompany.com/report/chromatin-immunoprecipitation-chip-sequencing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovations and Emerging Trends in the Chromatin Immunoprecipitation (ChIP) Sequencing Industry
Companies in this market are increasingly focusing on cutting-edge technologies such as hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing) to improve the precision and throughput of epigenomic studies. This advancement is pivotal in accelerating drug discovery and personalized medicine efforts.

For example, in June 2024, Epigenica, a life sciences technology company based in Sweden, introduced its EpiFinder Platform, which incorporates patented hmqChIP-seq technology. This platform facilitates high-throughput, multiplex quantitative epigenomic profiling, allowing researchers to simultaneously generate 192 genome-wide profiles from up to 24 samples. Such innovation dramatically streamlines large-scale experiments by boosting efficiency and reducing costs.

Detailed Market Segmentation and Forecasts in the Global Chromatin Immunoprecipitation (ChIP) Sequencing Market
The chromatin immunoprecipitation sequencing market is segmented as follows:

By Type:
- DNase-Sequencing
- FAIRE-Sequencing

By Technology:
- Targeted Sequencing and Re-Sequencing
- Whole Genome Sequencing and Whole Exome Sequencing

By Workflow:
- Pre-Sequencing
- Sequencing
- Data Analysis

By Application:
- Consumables and Reagents
- Service
- Other Applications

By End-User:
- Academic Research Institutes
- Clinical Research Institutes
- Hospitals and Clinics
- Pharmaceuticals and Biotechnology Companies
- Other End Users

Additional subcategories include:
- DNase-Sequencing: DNase I Hypersensitivity Mapping and DNase-Seq for Open Chromatin Regions
- FAIRE-Sequencing: Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) and FAIRE-Seq for Active Regulatory Regions

This comprehensive segmentation highlights the diverse applications and technological approaches fueling growth within the chromatin immunoprecipitation sequencing market.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.